CGEM - Cullinan Oncology GAAP EPS of -$0.82 beats by $0.15
2023-08-10 12:11:29 ET
- Cullinan Oncology press release ( NASDAQ: CGEM ): Q2 GAAP EPS of -$0.82 beats by $0.15 .
- Cash and investment position of $512.1 million as of June 30, 2023 continues to provide runway into 2026
For further details see:
Cullinan Oncology GAAP EPS of -$0.82 beats by $0.15